Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

171

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09DA07	MICARDIS PLUS	B	Telmisartan - 80mg, Hydrochlorothiazide - 12.5mg		Tablet	1,101,951 L.L
H02AB01	DIPROFOS	B	Betamethasone (dipropionate) - 5mg/ml, Betamethasone (sodium phosphate) - 2mg/ml		Injectable suspension	446,156 L.L
L04AA42	MAYZENT	B	Siponimod - 0.25mg	0.25mg	Tablet, film coated	124,258,444 L.L
N04BA02	SINEMET	B	Levodopa - 100mg, Carbidopa - 25mg		Tablet	2,742,335 L.L
C07AB12	NEBILET	B	Nebivolol HCl - 5mg	5mg	Tablet, scored	694,767 L.L
D01AC12	LOMEXIN	B	Fenticonazole nitrate - 2g/100g	2%	Cream	758,029 L.L
H02AB02	DECADRON	B	Dexamethasone - 0.5mg/5ml	0.5mg/5ml	Elixir	449,227 L.L
L04AA42	MAYZENT	B	Siponimod - 2mg	2mg	Tablet, film coated	124,258,444 L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 25mg		Tablet, film coated	933,971 L.L
D01AC14	DERMOFIX	B	Sertaconazole nitrate - 20mg/g	2%	Cream	382,995 L.L
J01XX08	ZYVOX IV	B	Linezolide - 600mg/300ml	600mg/300ml	Injectable solution	4,414,523 L.L
L01BA04	ALIMTA	B	Pemetrexed (disodium) - 100mg	100mg	Injectable concentrated powder for solution	16,854,009 L.L
L04AA44	RINVOQ	B	Upadacitinib - 15mg	15mg	Tablet, prolonged release	45,469,094 L.L
R03AK06	SERETIDE DISKUS 500	B	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 500mcg/inhalation		Inhalation powder	3,199,689 L.L
R06AX27	AERIUS	B	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	403,153 L.L
B05AA06	GELASPAN	B	Gelatine, succinylated - 4%	4%	Injectable solution	9,107,572 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 8g/100g	8%	Film forming solution	756,583 L.L
A10BA02	GLUCOPHAGE XR	B	Metformin HCl - 500mg	500mg	Tablet, prolonged release	484,421 L.L
A16AB02	CEREZYME	B	Imiglucerase - 400IU	400IU	Injectable lyophilised powder for solution	128,412,818 L.L
B05AA07	VOLUVEN	B	Starch poly(O-2-Hydroxyethyl) - 6%	6%	Injectable solution	987,724 L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	933,971 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 8g/100g	8%	Film forming solution	756,583 L.L
B05BA01	AMINOVEN 10%	B	Glacial Acetic Acid 99% - 5.297g/l, L-Proline - 15.0g/l, L-Alanine - 15.0g/l, Glycine - 14.0g/l, L-Histidine - 3.00g/l, L-Arginine - 12.0g/l, L-Valine - 6.20g/l, L-Tryptophan - 2.00g/l, L-Threonine - 4.40g/l, L-Phenylalanine - 5.10g/l, L-Methionine - 4.30g/l, L-Lysine (monoacetate) - 6.60g/l, L-Leucine - 7.40g/l, L-Isoleucine - 5.00g/l		Injectable solution	951,440 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 1%	1%	Cream	325,210 L.L
J01DD07	CEFIZOX	B	Ceftizoxime (sodium) - 1g	1g	Injectable powder for solution	788,836 L.L
N04BB01	PK-MERZ	B	Amantadine (sulfate) - 100mg	100mg	Tablet, film coated	1,382,814 L.L
A16AB05	ALDURAZYME	B	Laronidase - 100U/ml	100U/ml	Injectable concentrate for solution	57,138,680 L.L
B05BA01	AMINOVEN INFANT	B	L-Leucine - 13g/l, L-Isoleucine - 8g/l, L-Lysine Acetate - 12g/l, L-Methionine - 3.12g/l, L-Phenylalanine - 3.75g/l, L-Threonine - 4.40g/l, L-Tryptophan - 2.01g/l, L-Valine - 9g/l, Arginine - 7.5g/l, L-Histidine - 4.76g/l, Glycine - 4.15g/l, L-Taurine - 0.40g/l, L-Serine - 7.67g/l, L-Alanine - 9.3g/l, L-Proline - 9.71g/l, N-Acetyl-L-Tyrosine - 5.176g/l, N-Acetyl-L-Cysteine - 0.70g/l, L-Malic Acid - 2.62g/l	10%	Injectable solution	880,217 L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 20mg, Hydrochlorothiazide - 25mg		Tablet, film coated	900,374 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/g	1%	Cream	616,824 L.L

...

171

...